Boiron S.A.
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a BOIRF research report →
Companywww.boiron.fr
Boiron SA manufactures and sells homeopathic medicines in France, rest of Europe, North America, and internationally. The company offers non-proprietary, proprietary, branded homeopathic medicines. Its branded homeopathic medicines include Oscillococcinum to treat influenza symptoms, such as fever, chills, headaches, and aches; Stodal and Stodaline for treating coughs; Arnigel for adjunctive local treatment of benign trauma in the absence of open wounds; Camilia for the treatment of teething problems for babies; and Sédatif PC to treat anxiety and emotional, and minor sleep disorders.
- CEO
- Thierry Boiron
- IPO
- 1996
- Employees
- 2,469
- HQ
- Messimy, FR
Price Chart
Valuation
- Market Cap
- $553.86M
- P/E
- 14.54
- P/S
- 0.93
- P/B
- 1.21
- EV/EBITDA
- 6.32
- Div Yield
- 4.46%
Profitability
- Gross Margin
- 72.98%
- Op Margin
- 7.06%
- Net Margin
- 6.51%
- ROE
- 8.57%
- ROIC
- 5.70%
Growth & Income
- Revenue
- $487.56M · -1.15%
- Net Income
- $11.34M · -68.36%
- EPS
- $0.65 · -68.45%
- Op Income
- $15.74M
- FCF YoY
- -14.06%
Performance & Tape
- 52W High
- $32.28
- 52W Low
- $24.00
- 50D MA
- $30.00
- 200D MA
- $28.02
- Beta
- 0.23
- Avg Volume
- 60.685
Get TickerSpark's AI analysis on BOIRF
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Our BOIRF Coverage
We haven't published any research on BOIRF yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate BOIRF Report →